BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9154766)

  • 21. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
    Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
    J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
    Rey R; Lordereau-Richard I; Carel JC; Barbet P; Cate RL; Roger M; Chaussain JL; Josso N
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1220-6. PubMed ID: 8077315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.
    Lee MM; Donahoe PK; Hasegawa T; Silverman B; Crist GB; Best S; Hasegawa Y; Noto RA; Schoenfeld D; MacLaughlin DT
    J Clin Endocrinol Metab; 1996 Feb; 81(2):571-6. PubMed ID: 8636269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement.
    Rey RA; Belville C; Nihoul-Fékété C; Michel-Calemard L; Forest MG; Lahlou N; Jaubert F; Mowszowicz I; David M; Saka N; Bouvattier C; Bertrand AM; Lecointre C; Soskin S; Cabrol S; Crosnier H; Léger J; Lortat-Jacob S; Nicolino M; Rabl W; Toledo SP; Baş F; Gompel A; Czernichow P; Josso N
    J Clin Endocrinol Metab; 1999 Feb; 84(2):627-31. PubMed ID: 10022428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
    Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
    J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness.
    Grinspon RP; Ropelato MG; Bedecarrás P; Loreti N; Ballerini MG; Gottlieb S; Campo SM; Rey RA
    Clin Endocrinol (Oxf); 2012 May; 76(5):698-705. PubMed ID: 22098623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptorchidism and persistence of Müllerian remnants in a normal male.
    Barriola M; Jimenez J; Gutierrez-Hoyos A; Tovar JA
    Z Kinderchir; 1981 Aug; 33(4):369-73. PubMed ID: 6119858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
    Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N
    Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrinology of cryptorchidism].
    Cacciari E; Cicognani A
    Pediatr Med Chir; 1989; 11(6):585-90. PubMed ID: 2576878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine analysis of childhood monorchism.
    Palmer LS; Gill B; Kogan SJ
    J Urol; 1997 Aug; 158(2):594-6. PubMed ID: 9224372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The müllerian inhibitor and mammalian sexual development.
    Behringer RR
    Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Persistent müllerian duct syndrome (males with uterus): a pediatric problem].
    Zeller J; Imbeaud S; Rey R; Adamsbaum C; Fourmaintraux A; Donnet J; van Kote G; Josso N; Chaussain JL
    Arch Pediatr; 1994 Nov; 1(11):991-7. PubMed ID: 7834048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic effects of müllerian inhibiting substance (MIS)?
    Janssens JP; Noto V; van Tendeloo G; Bonte J; de Loecker W
    Anticancer Res; 1988; 8(4):781-4. PubMed ID: 3178166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of seminiferous tubule function (anti-müllerian hormone).
    Rey R
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Sep; 14(3):399-408. PubMed ID: 11097782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered serum profile of inhibin B, Pro-alphaC and anti-Müllerian hormone in prepubertal and pubertal boys with varicocele.
    Trigo RV; Bergadá I; Rey R; Ballerini MG; Bedecarrás P; Bergadá C; Gottlieb S; Campo S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):758-64. PubMed ID: 15163341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
    Weniger JP; Zeis A
    Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-müllerian hormone in children with androgen insensitivity.
    Rey R; Mebarki F; Forest MG; Mowszowicz I; Cate RL; Morel Y; Chaussain JL; Josso N
    J Clin Endocrinol Metab; 1994 Oct; 79(4):960-4. PubMed ID: 7962305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life.
    Baker ML; Hutson JM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):245-7. PubMed ID: 8421093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.